University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
-
New hope for AML patients too fragile for strong chemo?
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests whether adding the anti-inflammatory drug dexamethasone to a standard low-intensity treatment (venetoclax plus another chemo drug) is safe and tolerable for adults with newly diagnosed acute myeloid leukemia (AML) who cannot handle strong chemotherapy…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New program aims to stop deadly clots in cancer patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a special program can help doctors better prevent blood clots in cancer patients who are starting treatment. About 25 patients and their doctors will take part. Doctors will get training and use a checklist to assess clot risk and decide on blood-thinn…
Phase: NA • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:00 UTC